Your browser doesn't support javascript.
loading
Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer: The UNICANCER PRODIGE18 Randomized Clinical Trial.
Bennouna, Jaafar; Hiret, Sandrine; Bertaut, Aurelie; Bouché, Olivier; Deplanque, Gael; Borel, Christian; François, Eric; Conroy, Thierry; Ghiringhelli, François; des Guetz, Gaëtan; Seitz, Jean-François; Artru, Pascal; Hebbar, Mohamed; Stanbury, Trevor; Denis, Marc G; Adenis, Antoine; Borg, Christophe.
Affiliation
  • Bennouna J; Department of Hepatogastroenterology, Digestive Oncology, Centre Hospitalier Universitaire de Nantes, Nantes, France.
  • Hiret S; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint-Herblain, France.
  • Bertaut A; Department of Medical Oncology, Georges-François Leclerc Cancer Center, Dijon, France.
  • Bouché O; Department of Hepatogastroenterology, Centre Hospitalier Universitaire Robert Debré, Reims, France.
  • Deplanque G; Department of Medical Oncology, Hôpital Saint-Joseph, Paris, France.
  • Borel C; Department of Medical Oncology, Centre Paul Strauss, Strasbourg, France.
  • François E; Department of Medical Oncology, Centre Antoine-Lacassagne, Nice, France.
  • Conroy T; Institut de Cancérologie de Lorraine, et Vandoeuvre-Lès Nancy, Université de Lorraine, Vandoeuvre-Lès Nancy, France.
  • Ghiringhelli F; Department of Medical Oncology, Georges-François Leclerc Cancer Center, Dijon, France.
  • des Guetz G; Department of Medical Oncology, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Seitz JF; Department of Hepatogastroenterology, Digestive Oncology, Assistance Publique-Hôpitaux de Marseille La Timone, Marseille, France.
  • Artru P; Hôpital Privé Jean Mermoz, Lyon, France.
  • Hebbar M; Department of Medical Oncology, University Hospital, Lille, France.
  • Stanbury T; UNICANCER, Paris, France.
  • Denis MG; Centre Hospitalier Universitaire de Nantes, Nantes, France.
  • Adenis A; Department of Medical Oncology, Centre Oscar Lambret, Lille, France.
  • Borg C; Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon, Besançon, France.
JAMA Oncol ; 5(1): 83-90, 2019 01 01.
Article in En | MEDLINE | ID: mdl-30422156
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Proto-Oncogene Proteins p21(ras) / Bevacizumab / Cetuximab Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: JAMA Oncol Year: 2019 Document type: Article Affiliation country: France Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Proto-Oncogene Proteins p21(ras) / Bevacizumab / Cetuximab Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: JAMA Oncol Year: 2019 Document type: Article Affiliation country: France Country of publication: United States